Literature DB >> 4080124

Brain tumors during the first twenty-four months of life.

T Tomita, D G McLone.   

Abstract

One hundred patients with brain tumors were diagnosed and treated during the first 24 months of life. They represent 16% of 608 children with brain tumors treated from 1952 through 1984. The most common histological type of brain tumors during the first 24 months are benign astrocytoma, medulloblastoma, and choroid plexus papilloma. The tumor location is distributed relatively evenly among the cerebellum and the 4th ventricle, the cerebral hemisphere (including the lateral ventricle), and the suprasellar region and 3rd ventricle. The chief presenting signs and symptoms are a full fontanelle, macrocephaly, changes of behavior, and delayed developmental milestones. Localizing signs are infrequent. Ninety-two patients underwent craniotomy with a one-month surgical mortality rate of 12%. The surgical mortality rate was 5.6% among 36 recent patients diagnosed by computed tomography. The 5-year survival rate is 41% in the patients younger than 12 months and 74% in patients diagnosed during the 2nd year of life. This study indicates the validity of Collins' rule for medulloblastomas during the first 24 months of life, but not for benign or malignant astrocytomas.

Entities:  

Mesh:

Year:  1985        PMID: 4080124     DOI: 10.1227/00006123-198512000-00008

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  29 in total

1.  Congenital brain tumors in a series of 56 patients.

Authors:  Elżbieta Jurkiewicz; Agnieszka Brożyna; Wiesława Grajkowska; Monika Bekiesińska-Figatowska; Paweł Daszkiewicz; Katarzyna Nowak; Katarzyna Malczyk; Jerzy Walecki; Danuta Perek; Małgorzata Syczewska
Journal:  Childs Nerv Syst       Date:  2012-05-31       Impact factor: 1.475

2.  Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma?

Authors:  S Dupuis-Girod; O Hartmann; E Benhamou; F Doz; F Mechinaud; E Bouffet; C Coze; C Kalifa
Journal:  J Neurooncol       Date:  1996-01       Impact factor: 4.130

3.  MOPP chemotherapy without irradiation as primary postsurgical therapy for brain tumors in infants and young children.

Authors:  J L Ater; J van Eys; S Y Woo; B Moore; D R Copeland; J Bruner
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

4.  Report of a case of congenital glioblastoma multiforme: an immunohistochemical study.

Authors:  D Mazzone; G Magro; A Lucenti; S Grasso
Journal:  Childs Nerv Syst       Date:  1995-05       Impact factor: 1.475

5.  CRANIOPHARYNGIOMA DURING INFANCY: (A Case Report).

Authors:  H S Bhatoe
Journal:  Med J Armed Forces India       Date:  2017-06-26

6.  Brain tumors with symptomatic onset in the first two years of life.

Authors:  M R Balestrini; R Micheli; L Giordano; G Lasio; S Giombini
Journal:  Childs Nerv Syst       Date:  1994-03       Impact factor: 1.475

7.  Brain tumors in children under 1 year of age: emphasis on the relationship of prognostic factors.

Authors:  Roberto Rivera-Luna; Aurora Medina-Sanson; Carlos Leal-Leal; Francisco Pantoja-Guillen; Marta Zapata-Tarrés; Rocio Cardenas-Cardos; Rafael Barrera-Gómez; Fernando Rueda-Franco
Journal:  Childs Nerv Syst       Date:  2003-05-06       Impact factor: 1.475

8.  Supratentorial primitive neuroectodermal tumors in children.

Authors:  P B Dirks; L Harris; H J Hoffman; R P Humphreys; J M Drake; J T Rutka
Journal:  J Neurooncol       Date:  1996-07       Impact factor: 4.130

9.  Congenital brain tumors in Japan (ISPN Cooperative Study): specific clinical features in neonates.

Authors:  S Oi; T Kokunai; S Matsumoto
Journal:  Childs Nerv Syst       Date:  1990-03       Impact factor: 1.475

10.  Supratentorial cystic hemangioblastoma with infratentorial extension--a unique location and a rare infant case.

Authors:  Ismail H Tekkök; Aydin Sav
Journal:  Childs Nerv Syst       Date:  2006-03-14       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.